These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9028537

  • 21. Dynamics of bone turnover in children with GH deficiency treated with GH until final height.
    Baroncelli GI, Bertelloni S, Ceccarelli C, Cupelli D, Saggese G.
    Eur J Endocrinol; 2000 Jun; 142(6):549-56. PubMed ID: 10822216
    [Abstract] [Full Text] [Related]

  • 22. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M.
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D, Zwolińska D, Bednorz R, Owczarek H, Szymańska A, Nahaczewska W.
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [Abstract] [Full Text] [Related]

  • 27. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC, Hopkins E, Glorieux FH, Chrousos GP, Reynolds JC, Gundberg CM, Reing CM.
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [Abstract] [Full Text] [Related]

  • 28. Markers of type I and type III collagen turnover, insulin-like growth factors, and their binding proteins in cord plasma of small premature infants: relationships with fetal growth, gestational age, preeclampsia, and antenatal glucocorticoid treatment.
    Kajantie E, Hytinantti T, Koistinen R, Risteli J, Rutanen EM, Seppälä M, Andersson S.
    Pediatr Res; 2001 Apr; 49(4):481-9. PubMed ID: 11264430
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants.
    Namgung R, Tsang RC, Sierra RI, Ho ML.
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):224-8. PubMed ID: 8890070
    [Abstract] [Full Text] [Related]

  • 31. Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids.
    Wolthers OD, Hansen M, Juul A, Nielsen HK, Pedersen S.
    Pediatr Res; 1997 Jan; 41(1):44-50. PubMed ID: 8979288
    [Abstract] [Full Text] [Related]

  • 32. The insulin-like growth factor axis and collagen turnover during prednisolone treatment.
    Wolthers OD, Juul A, Hansen M, Müller J, Pedersen S.
    Arch Dis Child; 1994 Nov; 71(5):409-13. PubMed ID: 7529981
    [Abstract] [Full Text] [Related]

  • 33. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

  • 34. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3.
    Juul A, Skakkebaek NE.
    J Pediatr; 1997 Feb; 130(2):197-204. PubMed ID: 9042120
    [Abstract] [Full Text] [Related]

  • 35. Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children.
    Bini V, Igli Baroncelli G, Papi F, Celi F, Saggese G, Falorni A.
    Horm Res; 2004 Feb; 61(4):170-5. PubMed ID: 14726619
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Plasma levels of carboxy terminal propeptide of type I procollagen and pyridinoline cross-linked telopeptide of type I collagen in healthy school children.
    Kikuchi T, Hashimoto N, Kawasaki T, Kataoka S, Takahashi H, Uchiyama M.
    Acta Paediatr; 1998 Aug; 87(8):825-9. PubMed ID: 9736228
    [Abstract] [Full Text] [Related]

  • 40. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.